Applications Published 29 August 2001
Published: 17-May-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Antimicrobial compsn comprising Leptospermum scoparium and Melaleuca alternifolia oils
Coast Biologicals 1126759*Methods of delivering therapeutic agents to the urethra and a urethral suppository
Mulholland, S Grant 1126809*Treatment of skin with adenosine or adenosine analogue
University of Massachusetts 1126812* Skin moisturiser compsns containing a sebum control agent
Bristol-Myers Squibb 1126813*Method of using an aralkylosiloxane
General Electric Company 1126816*Controlled release drug delivery agent
Cardiac Pacemakers 1126820*Improved fast disintegrating tablet
Laboratoires de Produits Ethiques 1126821*Controlled release liquid delivery compsns with low initial drug burst
Atrix Laboratoires 1126822*A process for the preparation of suspensions of drug delivery particles for inhalation delivery
Chiesi Pharmaceuticals 1126823*Stabilised nucleic acid compsns and methods of preparation and use thereof
Selective Genetics 1126824*Use of xanthan gums for preparing pharmaceutical compsns
Rhodia Chimie 1126825*Multiparticulate modified release compsn
Church, Maria 1126826* Controlled delivery of active agents
Alza Corp 1126827*Oral administration of adenosine analogs
Supergen 1126828*Paricles coated with granulated crystalline ibuprofen
Laboratoires des Produits Ethiques Ethypharm 1126829*Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
Bristol-Myers Squibb 1126830*Method for treating insulin resistance through hepatic nitric oxide
The University of Manitoba 1126831*Conductance of improperly folded proteins through the secretory pathway
Yale University 1126832*Oxadiazole, thiadiazole and triazole derivatives and combinatorial libraries thereof
Trega Biosciences 1126833*Analgesic regimen
Ortho-McNeil Pharmaceutical 1126834*Method for preventing increased iridial pigmentation during prostaglandin treatment
Synphora 1126835*Benzamide potassium channel inhibitors
Merck 1126836*Fulvic acid and its use in the treatment of various conditions
Enerkom 1126837*Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compsns and methods of use
Nitromed 1126838*Substituted phenethylsulphones and method of reducing TNF alpha levels
Celgene 1126839*5HT(1) receptor agonists and metoclopramide for the treatment of migraine
Pfizer Products 1126840*Method of treating migraines and pharmaceutical compsns
Merck 1126841*Inhibition of the formation of vascular hyperpermeability
BASF 1126842*Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme
Bristol-Myers Squibb 1126843*Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
Board of Regents of the University of Texas System 1126844*New use of immunosuppressants for MMP-mediated diseases
Fujisawa Pharmaceutical 1126845*Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder
Carlsson Research 1126846*Method for improving the pharmacokinetics of tipranavir
Pharmacia & Upjohn 1126847*Plastics container containing stabilised drug drug formulations
Darwin Discovery 1126848*Heterocyclic potassium channel inhibitors
Merck 1126849*Treatment of disorders of the outer retina
Alcon Laboratories 1126850*Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
Pharmacia & Upjohn 1126851* Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
SmithKline Beecham 1126852*Controlled delivery of antidepressants
Alza Corp 1126853*Benzoazepine and analogues thereof useful as growth hormone secretagogues
Bristol-Myers Squibb 1126854*Methods for preventing/treating damage to sensory hair cells and cochlear neurons
Cephalon 1126855*Compounds and their therapeutic use with diabetic complications.
Fox Chase Cancer Centre 1126856*A method of activating T cells and agents useful for same
The Walter and Eliza Hall Institute of Medical Research 1126857*Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells
Kirkpatrick, Shaun 1126858*Blood leukocyte apheresis for treatment of disease
Japan Immunoisearch Laboratories 1126859*Immunomodulatory factors for immunosuppressant and antiallergic treatment
The University of Nottingham 1126860*Compsns containing oleum melaleuca
Safe'n'Sound Solutions 1126861*Herbal compsns for treating gastrointestinal disorders
Chinese Medicines Scientific Consultants 1126862*Vascular endothelial growth factor-like protein from ORF virus NZ2 binds and activates mammalian VEGF receptors
Ludwig Institute for Cancer Research 1126863*Binding moieties for human parvovirus B19
Dyax Corp 1126864*Methods and compsns for treating or preventing peripheral neuropathies
Biogen 1126865*A method for inhibition of phospholambin activity for the treatment of cardiac disease and heart failure
The Regents of the University of California 1126866*A compsn for the prevention and/or treatment of atherosclerosis.
Cardimmune 1126867*Methods for regulating angiogenesis and vascular integrity using TRK receptor ligands
Cornell Research Foundation 1126869*Combonation therapy with VIP antagonist
The Government of the USA as represented by the Dept of Health and Human Services 1126871*Method for enhancing the proliferation of inner ear hair cells using ligands for HER2 and/or HER3 receptors
Genentech 1126872*Mutlicomponent meningococcal vaccine
Microbiological Research Authority 1126874*Pharmaceutically active compsn and dispensing device
Schweiz. Serum-&Impfinstitut Bern 1126875*
